Latest news
Autolus Raises AUCATZYL Outlook, Secures New Credit Facility - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 12:34:00 GMTAutolus Therapeutics Reports Preliminary Q2 2026 AUCATZYL Revenue of About $45 Million, Raises FY 2026 Sales Guidance and Secures $75 Million Financing - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:20:00 GMT